Apollo Hospitals Enterprise Limited
APOLLOHOSP · Hospitals · NSE
₹7,521
Current Market Price
Fair Value (DCF)
₹4,314
Margin of Safety
-42.6%
Updated just now
YieldIQ Score
53/100
Piotroski F-Score
6/9
Economic Moat
Narrow
Confidence
42%
ROE
16.7%
Debt/Equity
0.00
WACC
9.8%
Market Cap
₹1.08 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
15.3%
Return on capital employed
EV / EBITDA
32.5×
Enterprise multiple
Debt / EBITDA
1.5×
Leverage vs earnings
Interest Coverage
5.8×
EBIT covers interest
Current Ratio
1.54×
Short-term liquidity
Asset Turnover
1.12×
Revenue per ₹ of assets
Revenue CAGR (3Y)
11.8%
3-year revenue growth
Revenue CAGR (5Y)
17.1%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹7,521
Bear case
₹2,560.86
MoS -193.7%
Base case
₹4,313.55
MoS -74.4%
Bull case
₹5,842.36
MoS -28.7%
Ratio Trends
APOLLOHOSP · last 8 annual periods
ROE
16.7%
ROCE
22.9%
Operating Margin
—
Debt / Equity
0.63×
PE
65.8×
EV / EBITDA
31.1×
Historical Financials
APOLLOHOSP · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹10.6K Cr | ₹14.7K Cr | ₹16.6K Cr | ₹19.1K Cr | ₹21.6K Cr | +19.6% |
| EBITDA | — | ₹2509 Cr | ₹2073 Cr | ₹2478 Cr | ₹3219 Cr | +6.4% |
| EBIT | ₹670 Cr | ₹1957 Cr | ₹1525 Cr | ₹1812 Cr | — | +28.2% |
| PAT | ₹137 Cr | ₹1108 Cr | ₹845 Cr | ₹935 Cr | ₹1446 Cr | +80.3% |
| EPS (diluted) | ₹10.74 | ₹73.42 | ₹56.97 | ₹62.50 | — | +55.3% |
| CFO | ₹1273 Cr | ₹1616 Cr | ₹1377 Cr | ₹1920 Cr | ₹2136 Cr | +13.8% |
| CapEx | — | — | — | — | ₹-1713 Cr | — |
| FCF | — | — | — | — | ₹424 Cr | +0.0% |
| Total Assets | — | ₹13.3K Cr | ₹14.4K Cr | ₹16.8K Cr | ₹20.7K Cr | +11.7% |
| Total Debt | — | — | ₹773 Cr | ₹926 Cr | ₹5419 Cr | +62.7% |
| Shareholders' Equity | — | — | ₹6197 Cr | ₹6935 Cr | ₹8653 Cr | +8.7% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
APOLLOHOSP vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| MAXHEALTH MAXHEALTH | — | — | Pending | 11.5% | — |
| FORTIS Fortis Healthcare Limited | -47.8% | 58 | Overvalued | 8.4% | — |
| NH NH | — | — | Pending | 21.8% | — |
| ASTERDM ASTERDM | — | — | Pending | 147.3% | — |
| MEDANTA MEDANTA | — | — | Pending | 14.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
14 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹74.75/sh
Last payout
2026-02-16
₹10.00
Peak payout
₹11.75
Trailing yield
0.27%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Apollo Hospitals Enterprise Limited (APOLLOHOSP.NS) trades at 7521.00 vs a model fair value of 4313.55, a gap of -42.6%. Piotroski F-scor...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of APOLLOHOSP →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for APOLLOHOSP →
Compare
Head-to-head with peers
Compare APOLLOHOSP side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse APOLLOHOSPNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.